NCT03189641View on ClinicalTrials.gov

Clinical Trial of Cilostazol Eluting Stent System (CES-1) in De Novo Coronary Artery Lesions

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

May 31, 2017

Primary Completion Date

March 27, 2020

Study Completion Date

July 26, 2024

Conditions
Coronary Artery Disease
Interventions
DEVICE

Cilostazol eluting stent system (CES-1)

Implantation of drug eluting stent

Trial Locations (6)

Unknown

Tokai University Hospital, Isehara

Kitasato University Hospital, Sagamihara

Saiseikai Yokohamashi Tobu Hospital, Yokohama

Showa University Fujigaoka Hospital, Yokohama

Mitsui Memorial Hospital, Chiyoda City

Teikyo University Hospital, tabashi City

All Listed Sponsors
lead

JIMRO Co., Ltd.

INDUSTRY

NCT03189641 - Clinical Trial of Cilostazol Eluting Stent System (CES-1) in De Novo Coronary Artery Lesions | Biotech Hunter | Biotech Hunter